Downregulation of the microRNA biogenesis components and its association with poor prognosis in hepatocellular carcinoma

Cancer Science

Volumn 104, Issue 5, 2013, Pages 543-551

  Kitagawa, Noriyuki ^a,b   Ojima, Hidenori ^a   Shirakihara, Takuya ^a   Shimizu, Hiroko ^a   Kokubu, Akiko ^a   Urushidate, Tomoko ^a   Totoki, Yasushi ^a   Kosuge, Tomoo ^c   Miyagawa, Shinichi ^b   Shibata, Tatsuhiro ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DICER; HISTONE H3; MICRORNA; PROTEIN P68; PROTEIN P72;

ADULT; AGED; ARTICLE; BIOGENESIS; CONTROLLED STUDY; DOWN REGULATION; EPIGENETICS; FEMALE; GENE; GENE AGO3; GENE AGO4; GENE DGCR8; GENE EXPRESSION; GENE PIWIL4; HISTONE METHYLATION; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HEP G2 CELLS; HISTONES; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; PROMOTER REGIONS, GENETIC; RISK FACTORS;

EID: 84876406080     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12126     Document Type: Article

References (37)

1. Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor Robinson SD. Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol 2008; 14: 4300-308.
2. Fan JG, Farrell GC. Prevention of hepatocellular carcinoma in nonviral-related liver diseases. J Gastroenterol Hepatol 2009; 24: 712-19.
3. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-97.
4. Lu J, Getz G, Miska EA et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-8.
5. Fukuda T, Yamagata K, Fujiyama S et al. DEAD-box RNA helicase subunits of the Drosha complex are required for processing of rRNA and a subset of microRNAs. Nat Cell Biol 2007; 9: 604-11.
6. Thomson JM, Newman M, Parker JS, Morin Kensicki EM, Wright T, Hammond SM. Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev 2006; 20: 2202-7.
7. Gregory RI, Yan KP, Amuthan G et al. The Microprocessor complex mediates the genesis of microRNAs. Nature 2004; 432: 235-40.
8. Peters L, Meister G. Argonaute proteins: mediators of RNA silencing. Mol Cell 2007; 26: 611-23.
9. Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, Miyazono K. Modulation of microRNA processing by p53. Nature 2009; 460: 529-33.
10. Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A. Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. Mol Cell 2010; 39: 373-84.
11. Suzuki HI, Miyazono K. Dynamics of microRNA biogenesis: crosstalk between p53 network and microRNA processing pathway. J Mol Med 2010; 88: 1085-94.
12. Merritt WM, Lin YG, Han LY et al. Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med 2008; 359: 2641-50.
13. Lin RJ, Lin YC, Chen J et al. MicroRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma. Cancer Res 2010; 70: 7841-50.
14. Hill DA, Ivanovich J, Priest JR et al. DICER1 mutations in familial pleuropulmonary blastoma. Science 2009; 325: 965.
15. Heravi-Moussavi A, Anglesio MS, Cheng SW et al. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers. N Engl J Med 2012; 366: 234-42.
16. Melo SA, Moutinho C, Ropero S et al. A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells. Cancer Cell 2010; 18: 303-15.
17. Sekine S, Ogawa R, Ito R et al. Disruption of Dicer1 induces dysregulated fetal gene expression and promotes hepatocarcinogenesis. Gastroenterology 2009; 136: 2304-315.
18. Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 2007; 39: 673-7.
19. Yano H, Maruiwa M, Murakami T et al. A new human pleomorphic hepatocellular carcinoma cell line, KYN-2. Acta Pathol Jpn 1988; 38: 953-66.
20. MacNab GM, Alexander JJ, Lecatsas G, Bey EM, Urbanowicz JM. Hepatitis B surface antigen produced by a human hepatoma cell line. Br J Cancer 1976; 34: 509-15.
21. Huh N, Utakoji T. Production of HBs-antigen by two new human hepatoma cell lines and its enhancement by dexamethasone. Gann 1981; 72: 178-9.
22. Lin X, Asgari K, Putzi MJ et al. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide. Cancer Res 2001; 61: 8611-16.
23. Wang Y, Lu Y, Toh ST et al. Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3. J Hepatol 2010; 53: 57-66.
24. Takagi H, Sasaki S, Suzuki H et al. Frequent epigenetic inactivation of SFRP genes in hepatocellular carcinoma. J Gastroenterol 2008; 43: 378-89.
25. Ohm JE, McGarvey KM, Yu X et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet 2007; 39: 237-42.
26. Shen X, Liu Y, Hsu YJ et al. EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency. Mol Cell 2008; 32: 491-502.
27. Montgomery ND, Yee D, Chen A et al. The murine polycomb group protein Eed is required for global histone H3 lysine-27 methylation. Curr Biol 2005; 15: 942-7.
28. Izzotti A, Calin GA, Arrigo P, Steele VE, Croce CM, De FS. Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J 2009; 23: 806-12.
29. Wei W, Ba Z, Gao M et al. A role for small RNAs in DNA double-strand break repair. Cell 2012; 149: 101-12.
30. Francia S, Michelini F, Saxena A et al. Site-specific DICER and DROSHA RNA products control the DNA-damage response. Nature 2012; 488: 231-5.
31. Karube Y, Tanaka H, Osada H et al. Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci 2005; 96: 111-15.
32. Martello G, Rosato A, Ferrari F et al. A microRNA targeting dicer for metastasis control. Cell 2010; 141: 1195-207.
33. Su X, Chakravarti D, Cho MS et al. TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs. Nature 2010; 467: 986-90.
34. Melo SA, Ropero S, Moutinho C et al. A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat Genet 2009; 41: 365-70.
35. Cairo S, Wang Y, de Reyniès A et al. Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer. Proc Natl Acad Sci U S A 2010; 107: 20471-6.
36. Sudo T, Utsunomiya T, Mimori K et al. Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma. Br J Cancer 2005; 92: 1754-8.
37. Wang C, Liu Z, Woo CW et al. EZH2 Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR. Cancer Res 2012; 72: 315-24.